168 related articles for article (PubMed ID: 15262505)
1. Identification of glycosylation sites in the SU component of the Avian Sarcoma/Leukosis virus Envelope Glycoprotein (Subgroup A) by mass spectrometry.
Kvaratskhelia M; Clark PK; Hess S; Melder DC; Federspiel MJ; Hughes SH
Virology; 2004 Aug; 326(1):171-81. PubMed ID: 15262505
[TBL] [Abstract][Full Text] [Related]
2. A single glycosylation site within the receptor-binding domain of the avian sarcoma/leukosis virus glycoprotein is critical for receptor binding.
Delos SE; Burdick MJ; White JM
Virology; 2002 Mar; 294(2):354-63. PubMed ID: 12009877
[TBL] [Abstract][Full Text] [Related]
3. Receptor-induced conformational changes in the SU subunit of the avian sarcoma/leukosis virus A envelope protein: implications for fusion activation.
Delos SE; Godby JA; White JM
J Virol; 2005 Mar; 79(6):3488-99. PubMed ID: 15731243
[TBL] [Abstract][Full Text] [Related]
4. Novel monoclonal antibody directed at the receptor binding site on the avian sarcoma and leukosis virus Env complex.
Ochsenbauer-Jambor C; Delos SE; Accavitti MA; White JM; Hunter E
J Virol; 2002 Aug; 76(15):7518-27. PubMed ID: 12097564
[TBL] [Abstract][Full Text] [Related]
5. Residue Trp-48 of Tva is critical for viral entry but not for high-affinity binding to the SU glycoprotein of subgroup A avian leukosis and sarcoma viruses.
Zingler K; Young JA
J Virol; 1996 Nov; 70(11):7510-6. PubMed ID: 8892869
[TBL] [Abstract][Full Text] [Related]
6. Selection of a subgroup A avian leukosis virus [ALV(A)] envelope resistant to soluble ALV(A) surface glycoprotein.
Holmen SL; Federspiel MJ
Virology; 2000 Aug; 273(2):364-73. PubMed ID: 10915607
[TBL] [Abstract][Full Text] [Related]
7. Model of the TVA receptor determinants required for efficient infection by subgroup A avian sarcoma and leukosis viruses.
Melder DC; Pike GM; VanBrocklin MW; Federspiel MJ
J Virol; 2015 Feb; 89(4):2136-48. PubMed ID: 25473063
[TBL] [Abstract][Full Text] [Related]
8. Two different molecular defects in the Tva receptor gene explain the resistance of two tvar lines of chickens to infection by subgroup A avian sarcoma and leukosis viruses.
Elleder D; Melder DC; Trejbalova K; Svoboda J; Federspiel MJ
J Virol; 2004 Dec; 78(24):13489-500. PubMed ID: 15564460
[TBL] [Abstract][Full Text] [Related]
9. Glycosylation of gp116 and gp64 envelope proteins of yellow head virus of Penaeus monodon shrimp.
Soowannayan C; Cowley JA; Pearson RD; Wallis TP; Gorman JJ; Michalski WP; Walker PJ
J Gen Virol; 2010 Oct; 91(Pt 10):2463-73. PubMed ID: 20554800
[TBL] [Abstract][Full Text] [Related]
10. Identification of key residues in subgroup A avian leukosis virus envelope determining receptor binding affinity and infectivity of cells expressing chicken or quail Tva receptor.
Holmen SL; Melder DC; Federspiel MJ
J Virol; 2001 Jan; 75(2):726-37. PubMed ID: 11134286
[TBL] [Abstract][Full Text] [Related]
11. Identification of two residues within the LDL-A module of Tva that dictate the altered receptor specificity of mutant subgroup A avian sarcoma and leukosis viruses.
Rai T; Caffrey M; Rong L
J Virol; 2005 Dec; 79(23):14962-6. PubMed ID: 16282495
[TBL] [Abstract][Full Text] [Related]
12. Receptor-induced conformational changes in the subgroup A avian leukosis and sarcoma virus envelope glycoprotein.
Gilbert JM; Hernandez LD; Balliet JW; Bates P; White JM
J Virol; 1995 Dec; 69(12):7410-5. PubMed ID: 7494245
[TBL] [Abstract][Full Text] [Related]
13. Role of N-linked glycosylation in the activity of the Friend murine leukemia virus SU protein receptor-binding domain.
Battini JL; Kayman SC; Pinter A; Heard JM; Danos O
Virology; 1994 Jul; 202(1):496-9. PubMed ID: 8009864
[TBL] [Abstract][Full Text] [Related]
14. Identification of N-linked glycosylation sites in human nephrin using mass spectrometry.
Khoshnoodi J; Hill S; Tryggvason K; Hudson B; Friedman DB
J Mass Spectrom; 2007 Mar; 42(3):370-9. PubMed ID: 17212372
[TBL] [Abstract][Full Text] [Related]
15. A charged second-site mutation in the fusion peptide rescues replication of a mutant avian sarcoma and leukosis virus lacking critical cysteine residues flanking the internal fusion domain.
Melder DC; Yin X; Delos SE; Federspiel MJ
J Virol; 2009 Sep; 83(17):8575-86. PubMed ID: 19515762
[TBL] [Abstract][Full Text] [Related]
16. Analysis and function of prototype foamy virus envelope N glycosylation.
Lüftenegger D; Picard-Maureau M; Stanke N; Rethwilm A; Lindemann D
J Virol; 2005 Jun; 79(12):7664-72. PubMed ID: 15919919
[TBL] [Abstract][Full Text] [Related]
17. N-linked oligosaccharides of simian immunodeficiency virus envelope glycoproteins are dispensable for the interaction with the CD4 receptor.
Benjouad A; Babas T; Montagnier L; Bahraoui E
Biochem Biophys Res Commun; 1993 Jan; 190(2):311-9. PubMed ID: 8427576
[TBL] [Abstract][Full Text] [Related]
18. Avian sarcoma and leukosis virus-receptor interactions: from classical genetics to novel insights into virus-cell membrane fusion.
Barnard RJ; Elleder D; Young JA
Virology; 2006 Jan; 344(1):25-9. PubMed ID: 16364732
[TBL] [Abstract][Full Text] [Related]
19. HTLV-1 and -2 envelope SU subdomains and critical determinants in receptor binding.
Kim FJ; Manel N; Garrido EN; Valle C; Sitbon M; Battini JL
Retrovirology; 2004 Dec; 1():41. PubMed ID: 15575958
[TBL] [Abstract][Full Text] [Related]
20. Influence of N-linked glycans on intracellular transport of hepatitis C virus E1 chimeric glycoprotein and its role in pseudotype virus infectivity.
Beyene A; Basu A; Meyer K; Ray R
Virology; 2004 Jul; 324(2):273-85. PubMed ID: 15207615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
